Business Context and Reporting Period
Company: iSpecimen Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 28, 2021
Event: Entry into a Material Definitive Agreement for a private placement offering of equity securities.
Key Financial Metrics
This filing details a capital raise rather than operational financial results. Key metrics related to the transaction include:
- Aggregate Purchase Price: Up to $21,000,000.
- Estimated Net Proceeds: Approximately $19.65 million (after deducting placement agent fees and estimated expenses).
- Securities Issued:
- 1,749,999 shares of Common Stock.
- Warrants exercisable for 1,312,500 shares of Common Stock.
- Pricing: Combined purchase price of $12.00 per Share and three-quarters of a Warrant.
- Warrant Terms: Exercise price of $13.00 per Warrant Share; exercisable immediately upon issuance; expire 5.5 years from issuance.
- Placement Agent Fee: 6.0% of the aggregate purchase price plus expenses up to $75,000.
Note: The filing text does not provide current revenue, profit, cash flow, margins, or debt levels.
Material Changes and Transaction Details
The primary material change is the execution of a Securities Purchase Agreement with accredited investors. Key terms include:
- Closing Date: Expected on or about December 1, 2021, subject to customary conditions.
- Use of Proceeds: Working capital purposes.
- Registration Rights: The Company agreed to file registration statements for the resale of the Shares and Warrant Shares.
- Lock-up Agreements: Officers and directors agreed not to transfer Common Stock, Warrants, or convertible securities for 60 days after the Effective Date of the registration statement.
- Issuance Restrictions:
- 60-day blackout period on issuing new Common Stock or equivalents after the Effective Date.
- 18-month prohibition on Variable Rate Transactions after the Effective Date.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the net proceeds for working capital. The offering is conducted pursuant to a Placement Agency Agreement with ThinkEquity LLC.
Risks and Contingencies:
- Forward-Looking Statements: The report contains statements regarding intentions and expectations that are not guarantees of future performance.
- Registration Status: Securities are unregistered under the Securities Act of 1933 and may not be offered or sold absent registration or an applicable exemption until registered.
- Market Risks: Actual outcomes may differ materially from forecasts due to risks discussed in other SEC filings.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds received (expected ~$19.65 million).
- Confirm the filing and effectiveness of the registration statement for resale of the Shares and Warrant Shares.
- Monitor the Company's cash burn rate and working capital utilization post-closing.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and ownership limitations.
- Check for any subsequent issuances of equity that might violate the 60-day or 18-month issuance restrictions outlined in the agreement.